4. Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physio1261:El-E8 5. Kohner Response from the authors Dear Sir, We are grateful to Drs. Wascher and Toplak for their comments about our work involving photography of sural nerve vessels and fluorescein angiography. We accept their comment that there is a need to make similar observations in nonneuropathic diabetic patients who do not obviously have microvascular complications, but as the procedure involved was significantly invasive, although with no long-term complications, the number of non-neuropathic subjects volunteering to undergo the procedure during the study period was rather limited. This was in contrast to the number of neuropathic patients who were often very willing to volunteer for the procedure. We are now in the process of developing techniques for measuring nerve blood flow including fluorescein angiography through a
Corresponding author." Dr. S.Tesfaye, The Diabetes Center, Walton Hospital, Rice Lane, Liverpool L9 IAE, UK much reduced incision as the technique of light-guide spectrophotometry and laser Doppler has been developed and miniaturised. The other point raised by Drs. Wascher and Toplak was the need to match glycaemic control when comparing indices of blood flow. There was no significant difference in either mean HbA 1 or mean ambient blood glucose between both the diabetic groups, nor was there any correlation between the intensity of fluorescence and HbA 1, although admittedly the numbers could have been too small for a decent correlation.
We accept there is a great need to investigate the effect of various therapeutic agents on nerve blood flow (gamma linolenic acid, angiotensin converting enzyme inhibitors) and we hope that our miniaturised technique will allow such studies.
Yours sincerely, S. Tesfaye, J. D. Ward
Autonomic neuropathy: comparison of two screening procedures
Dear Sir, The EURODIAB IDDM Complications Study Group reported on the frequency of microvascular and acute complications in patients with insulin-dependent diabetes mellitus [1] . We would like to reflect on autonomic test results. Two tests were applied in the above-mentioned study: changes in heart rate (30/15 ratio) and in systolic blood pressure on standing. In 19.3 % of patients the 30/15 ratio was abnormal, while postural hypotension was observed in only 5.9 % of patients. Corresponding data in the Hungarian cohort were 37.1% and 7.9 %, respectively.
Corresponding author." Dr. E Kempler, I. Dept. of Medicine, Semmelweis University, Korfinyi S. u. 2/a, H-1083 Budapest, Hungary
The aim of the present study was to compare the efficacy of two different screening procedures: those of the EURODIAB IDDM Complications Study with those of our self-developed protocol.
We examined 206 IDDM patients (mean age: 32.2; range: 14-57years, mean duration of diabetes: 11.2; range: 0-43 years). Heart rate responses induced by deep breathing, Valsalva manoeuvre and standing up (35/15 ratio) and changes in blood pressure induced by standing and sustained handgrip were evaluated [2] . Eighty-three patients (40 %) had normal results in all five tests. Thirty-five patients (17 %) had one abnormal reflex test and 88 patients (43 %) had more than one abnormal reflex test. Abnormal heart rate response to deep breathing (in 84 patients) as well as abnormal 30/15 ratio (in 80 patients) were found significantly more often than an Letters to the editor abnormal Valsalva ratio (in 18 patients, p < 0.001 at both comparisons, McNemar test). Abnormal handgrip test (in 73 patients) was found significantly more often than an abnormal fall in blood pressure after standing up (in 3patients, p < 0.001, McNemar test). Abnormal blood pressure tests were present only if at least one of the heart rate tests was abnormal.
Data were analysed according to two different protocols. By the EURODIAB protocol 38 patients (18 %) had false negative results: they had normal 30/15 ratio and normal blood pressure response to standing; however, in 18 patients one, and in 20 patients, more than one of the three other tests were abnormal.
According to our protocol, heart rate response to deep breathing and 30/15 ratio were examined. In this case, only three patients (1.5 %) showed false-negative results, only the Valsalva ratio being abnormal. Both heart rate responses to deep breathing and standing were abnormal in 45 of our 206 patients. However, 32 of these 45 patients had abnormal results in at least one of the three other tests as well, indicating moderate to severe autonomic involvement. Thus, evaluation of these two tests also seems to provide some possibility for the assessment of severity of autonomic dysfunction.
Both protocols examined the 30/15 ratio. Evaluation of heart rate response to deep breathing instead of blood pressure response to standing seems to be a useful alternative way 1169 for screening autonomic function. Both tests equally require 60s.
Recently, we suggested evaluating heart rate responses to deep breathing and standing as the first step of diagnosis, as part of our rational diagnostic model for the assessment of autonomic function [3] . Indeed, for screening purposes in large epidemiological studies, examination of these two testsheart rate responses to deep breathing and standing -seems to be sufficient.
Yours sincerely, R Kempler, Zs. Ker6nyi, Gy. Tamfis
Prevalence of maternally inherited diabetes and deafness in diabetic populations in the Netherlands
Dear Sir, Previously we described a mutation in the mitochondrial encoded tRNA Leu(UUa) gene at position 3243 which cosegregated with non-insulin-dependent diabetes mellitus (NIDDM) and an associated deafness [1] . Additional publications have corroborated this finding [2] [3] [4] . Furthermore, we found that this mutation, which is also found in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS), is most likely the only mutation responsible for this subtype of diabetes, for which we proposed the name: Maternally Inherited Diabetes and Deafness (MIDD) [4] . Recently the prevalence of this mutation in selected French pedigrees with multiplex NIDDM was reported to be approximately 2 % [5]. Katagiri et al. [2] showed that the prevalence of this mitochondrial tRNA Leu(UUR) mutation in a Japanese group of subjects selected for maternal inheritance of diabetes is slightly more than 1%. Another study by Kadowaki et al. [3] indicated a prevalence of respectively 6 % and 2 % in Japanese patients with familial IDDM or NIDDM.
In this letter we present the prevalence of the tRNA Leu(UUR) gene mutation in two NIDDM populations in the Netherlands: one population consisting of 473 randomly selected NIDDM patients from three population-based studies in the Netherlands (The 'Hoorn Study', the ~ Study' and the 'Rotterdam Study'). All patients in this group were of Caucasian origin and over 40 years of age The other group comprised 28 pedigrees from the diabetes clinic of the University Hospital, Leiden, selected for the presence of NIDDM and deafness in at least two generations, and with a mode of inheritance agreeing with a maternal one. Total DNA isolation from leucocytes and detection of the 3243 mutation in the mitochondrial DNA was as described earlier [4] .
In the population-based group we detected two subjects out of 473 carrying the mutation, A020 and A135 (pedigrees shown in Fig. 1 ). Upon further investigation of these two pedigrees it appeared that individual A020 (age 27 years) suffers from a growth hormone deficiency. Her brother, mother, ma- NIDDM: ~ deafness; 9 NIDDM and deafness; ? unknown
